# Positive Node Traced Before Neoadjuvant Chemotherapy (NAC)

> **NCT03355261** · NA · COMPLETED · sponsor: **Shengjing Hospital** · enrollment: 110 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** complete remission (CR) group
- **PROCEDURE:** partial remission (PR) group
- **PROCEDURE:** stable disease (SD) group
- **PROCEDURE:** progressive disease (PD) group

## Key facts

- **NCT ID:** NCT03355261
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03355261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03355261, "Positive Node Traced Before Neoadjuvant Chemotherapy (NAC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03355261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*